AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 5.9 |
Market Cap | 103.10M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.28 |
PE Ratio (ttm) | -4.65 |
Forward PE | n/a |
Analyst | Buy |
Ask | 6 |
Volume | 2,830 |
Avg. Volume (20D) | 8,380 |
Open | 6.00 |
Previous Close | 5.99 |
Day's Range | 5.91 - 6.00 |
52-Week Range | 0.00 - 7.38 |
Beta | undefined |
About BHST
A detailed description of the company is not yet available....
Analyst Forecast
According to 2 analyst ratings, the average rating for BHST stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 118.49% from the latest price.
6 days ago · proactiveinvestors.com
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growthBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) CEO Ilan Sobel has reflected on 2024 as “a year of transformation and growth” for the company. In a letter to shareholders, Sobel highlighted the launc...
6 days ago · newsfilecorp.com
BioHarvest Issues Shareholder Letter and Provides Corporate UpdateVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc. , (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pione...
1 month ago · proactiveinvestors.com
BioHarvest Sciences CEO discusses Tate & Lyle partnership - ICYMIBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) this week announced a significant move for the company, a partnership with Tate & Lyle to develop plant-based sweeteners. The collaboration aims to cre...
1 month ago · proactiveinvestors.com
BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweetenersBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) announced it has partnered with Tate & Lyle PLC (LSE:TATE) to develop proprietary plant-based molecules for food and beverage ingredients. The partners...
1 month ago · proactiveinvestors.com
BioHarvest Sciences reports increased revenues, profits for Q3BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) reported robust financial performance for the third quarter ending September 30, 2024. The company achieved a 101% year-over-year revenue increase to $6....